Shrimp is a prominent aquaculture species all around the world. Disease outbreaks in the previous two decades have resulted in a significant drop in shrimp production. Bacterial, protozoan, or viral illnesses are all possible. Their growth is often enabled by environmental factors or poor nutrition which apply immune stress to the shrimp or provide food for the pathogens.
There has been an increase in prevalence of viral infections in shrimp farming such as White Spot Syndrome Virus (WSSV), Taura Syndrome Virus (TSV), Early Mortality Syndrome (EMS), Yellow Head/Gill Associated Virus (YHV/GAV), and others.
COVID-19 Impact analysis
In 2020, the COVID-19 had a negative impact on aquaculture production all across the world. All parts of the aquaculture value chain were affected by the economic consequences of nationwide stay-at-home orders and delayed export flows. The outbreaks and restrictions caused by COVID-19 had a severe influence on every link in the industry's supply chain.
The entire shrimp market has grown due to an increase in demand for shrimps during COVID-19 since it promotes immunity. White leg shrimp, giant tiger shrimps, gulf shrimps, blue shrimps, and royal red shrimps are among the most popular shrimp varieties consumed around the world. Shrimps are high in selenium, an antioxidant that aids in the maintenance of a healthy immune system. There was a rise in consumption owing to the fact that that it will contribute to the fight against COVID-19. Thereby increasing the shrimp’s disease diagnostic market.
Top Impacting Factors
- Shrimp disease diagnostics are in great demand due to the rise in prevalence of viral infections in the shrimp farming industry, which necessitates accurate diagnosis and prompt treatment.
- Companies are forming relationships with prestigious universities and government organizations, as well as R&D facilities, testing facilities, and ISO-accredited laboratories, to develop and commercialize novel shrimp disease diagnostics using pioneering technologies thereby accelerating the market growth.
- The shrimp disease diagnostics market to witness healthy growth due to huge demand in aquaculture biosecurity.
- Increase in demand for shrimp farming for human consumption and nutrient purposes is expected to drive the adoption of shrimp disease diagnostics around the world.
- Rise in demand for freshwater and marine shrimp farming, as well as increased global production of shrimp, are the major driving factors.
- The expansion of the shrimp disease diagnostic market is fueled by technological advancements in the field of aquaculture disease diagnosis.
Market Trends
New product launches to flourish the market
In 2018, Nutreco made an official announcement of its investment in the Israeli startup, ViAqua, as a vital part of its overall focus on combatting diseases in aquaculture.
In April 2021 Singapore-based aquaculture service provider Blue Aqua International has launched the Doctor Shrimp Academy and Clinic to support the shrimp industry globally, the company said in a statement. The platform will focus on five main cultured species of shrimp: Litopenaeus vannamei, Penaeus monodon, Marsupenaeus japonicus, Penaeus indicus, and Litopenaeus stylirostris. In partnership with Temasek Polytechnic, the academy will offer accepted students a series of specialized courses with hands-on practical training at Blue Aqua’s commercial shrimp farm in Singapore.
Key Benefits of the Report
- This study presents the analytical depiction of the Shrimps Disease Diagnostics along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Shrimps Disease Diagnostics market share.
- The current market is quantitatively analyzed to highlight the Shrimps Disease Diagnostics market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed Shrimps Disease Diagnostics market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Shrimps Disease Diagnostics Report
- Who are the leading market players active in the Shrimps Disease Diagnostics market?
- What current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What future projections would help in taking further strategic steps?
- What is "Shrimps Disease Diagnostics"?
- What is "Shrimps Disease Diagnostics" Market prediction in the future?
- Who are the leading global players in the "Shrimps Disease Diagnostics" Market?
- What are the current trends and predicted trends?
- What are the key benefits of the "Shrimps Disease Diagnostics" Market report?
Shrimps Disease Diagnostics Market, by Disease Report Highlights
| Aspects | Details |
 By Disease |
|
 By Kits |
|
 By End User |
|
 By Region |
|
 Key Market Players | Thermo Fisher Scientific Inc., FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp., SURE Marketing Company, Inc., Lab Ind Resource Sdn Bhd, REAGEN LLC, Aura Biotechnologies, HiMedia Laboratories, Speedy Assay Sdn Bhd |
Loading Table Of Content...
